ES
MARKETS / NYSE / NHI
NYSE · REAL ESTATE INVESTMENT TRUSTS · LARGE CAP

National Health Investors, Inc. NHI

18 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$80.1M
▲ 47.1% vs FY2024
Dividend streak
1 yrs
Raised every year since 2025
EPS · FY25
$3.02
Dividend / sh · FY25
$3.64
Payout · FY25
119%
ROE · FY25
9.8%
Net margin · FY25
177.6%
Dividend coverage
0.8×
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 80.1M
Revenue, FY2025 · full 18-year series below
Revenue Net income
0.080.160.240.320.10.12008201120142017202020232025
0.080.160.240.320.10.12016201920222025

178 cents of every revenue dollar became profit this year.

Per share
USD 3.02
Diluted EPS, FY2025
EPS Dividend
2463.643.022008201120142017202020232025
2463.643.022016201920222025

Earnings covered only a fraction of the dividend — the rest came from cash or borrowing.

Profitability
9.8%
Return on equity, FY2025
ROE
816249.8%2008201120142017202020232025
816249.8%2016201920222025
Operating margin—
Net margin177.6%
Return on assets5.3%

Each USD of equity produced 10 cents of profit this year.

Returned to shareholders
USD 169.7M
returned in FY2025 · dividends + net buybacks
Dividends paidUSD 169.7M
Net buybacks—
Share of profit119.4%
Consecutive raises1 years

USD 169.7M in dividends — 119% of the year's profit, so the payout drew on cash built up earlier.

Growth
—
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+30.8%
−10.0%
−0.2%
Net income
+28.9%
−5.1%
−0.5%
+4.9%
EPS, diluted
+26.8%
−6.1%
−2.6%
+1.3%
Dividend / share
+0.4%
−3.8%
+0.7%
+2.9%
Returned to shareholders
−18.5%
−2.7%
+3.1%
+6.4%

Compound annual rates per period — left blank where the series crosses a loss.

Share base
0.05B
Shares outstanding, FY2025
0.000.052008201120142017202020232025
0.040.052016201920222025
Change, 5 years+6.9%
Change, 10 years+25.8%

The share count grew 7% in five years — the same company, cut into more, smaller slices.

Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 2.8B
total assets, end of FY2025
Total assetsUSD 2.8B
EquityUSD 1.5B
CashUSD 19.6M

Equity funds 54% of total assets.

History
18 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
Revenue $B
0.1
0.1
0.0
0.0
0.0
0.0
0.3
0.3
0.3
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.1
Operating income $B
·
·
·
·
·
·
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.0
EBITDA $B
·
·
·
·
·
·
0.2
0.2
0.2
0.2
0.2
0.1
·
·
·
·
·
·
Income tax $B
·
·
·
·
·
·
·
0.0
0.0
0.0
−0.0
0.0
0.0
0.0
0.0
0.0
·
·
Net income $B
0.1
0.1
0.1
0.1
0.1
0.2
0.2
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
EPS, diluted $
3.02
3.13
3.13
1.48
2.44
4.14
3.67
3.67
3.87
3.87
3.95
3.04
3.74
3.26
2.92
2.50
2.32
2.07
Dividend / sh $
3.64
3.60
3.60
3.60
3.80
4.41
4.20
4.00
3.80
3.60
3.40
3.08
2.90
2.86
2.71
2.36
2.30
2.42
Payout %
119
113
115
244
164
105
112
107
96
91
84
99
80
87
84
96
100
149
ROE %
9.8
10.5
10.7
4.8
7.4
12.3
11.1
11.1
13.2
12.9
13.7
11.2
17.4
20.1
18.3
·
·
·
Shares out B
0.05
0.05
0.04
0.04
0.05
0.05
0.04
0.04
0.04
0.04
0.04
0.04
0.03
0.03
0.03
0.03
0.00
0.00

Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.

How we verifyAUDITED
35 of 35
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity

Every figure was compared against the original statement: 0 failures and 0 presentation gaps.

What we don’t show

We’d rather say what’s missing than fill the gap with an estimate.

P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed